Encompass Health Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Encompass Health Corporation (EHC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $14.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-26
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2016-06-30 was $300.00K, a 200.00% increase year-over-year.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2016-03-31 was $400.00K, a 78.95% decline year-over-year.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2015-12-31 was $2.00M.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2015-09-30 was $200.00K, a 81.82% decline year-over-year.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $14.60M, a 265.00% increase from fiscal 2024.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $4.00M, a 60.00% increase from fiscal 2023.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $2.50M, a 38.89% increase from fiscal 2022.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $1.80M, a 1700.00% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $14.60M 10-K · filed 2026-02-26 | ||||
| 2024-12-31 | $4.00M 10-K · filed 2026-02-26 | ||||
| 2023-12-31 | $2.50M 10-K · filed 2026-02-26 | ||||
| 2022-12-31 | $1.80M 10-K · filed 2025-02-28 | ||||
| 2021-12-31 | $100.00K 10-K · filed 2024-02-28 | ||||
| 2020-12-31 | $2.30M 10-K · filed 2023-02-27 | ||||
| 2019-12-31 | $3.60M 10-K · filed 2022-02-25 | ||||
| 2018-12-31 | $5.20M 10-K · filed 2021-02-26 | ||||
| 2017-12-31 | $29.00M 10-K · filed 2020-02-27 | ||||
| 2016-12-31 | $9.10M 10-K · filed 2019-02-27 | ||||
| 2016-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $700.00K 10-Q · filed 2016-07-29 | $2.70M derived: sum of 3 quarters · filed 2018-02-28 | $2.90M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | $400.00K 10-Q · filed 2016-04-28 | $2.40M derived: sum of 2 quarters · filed 2018-02-28 | $2.60M derived: sum of 3 quarters · filed 2018-02-28 | $2.70M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $2.20M derived: sum of 2 quarters · filed 2018-02-28 | $2.30M derived: sum of 3 quarters · filed 2018-02-28 | $4.20M 10-K · filed 2018-02-28 | $2.30M 10-K · filed 2016-02-25 |
| 2015-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $300.00K derived: sum of 2 quarters · filed 2016-07-29 | $2.20M 10-Q · filed 2015-10-29 | -$2.80M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2015-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $2.00M 10-Q · filed 2016-07-29 | -$3.00M derived: sum of 3 quarters · filed 2017-09-19 | -$1.90M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2015-03-31 | $1.90M 10-Q · filed 2016-04-28 | -$3.10M derived: sum of 2 quarters · filed 2017-09-19 | -$2.00M derived: sum of 3 quarters · filed 2017-09-19 | $700.00K derived: sum of 4 quarters · filed 2017-09-19 | |
| 2014-12-31 | -$5.00M derived: 8-K 12 month − 10-Q 9 month · filed 2017-09-19 | -$3.90M derived: sum of 2 quarters · filed 2017-09-19 | -$1.20M derived: sum of 3 quarters · filed 2017-09-19 | $2.40M 8-K · filed 2017-09-19 | $7.40M 10-K · filed 2015-03-02 |
| 2014-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $3.80M derived: sum of 2 quarters · filed 2015-10-29 | $7.40M 10-Q · filed 2015-10-29 | $8.10M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $6.30M 10-Q · filed 2015-07-30 | $7.00M derived: sum of 3 quarters · filed 2016-02-25 | $10.50M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-03-31 | $3.60M 10-Q · filed 2015-05-01 | $4.30M derived: sum of 2 quarters · filed 2016-02-25 | $7.80M derived: sum of 3 quarters · filed 2016-02-25 | ||
| 2013-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $4.20M derived: sum of 2 quarters · filed 2016-02-25 | $8.20M 10-K · filed 2016-02-25 | ||
| 2013-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $7.50M 10-Q · filed 2014-10-28 | |||
| 2013-06-30 | $4.00M 10-Q · filed 2014-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |